featured
Efficacy and Safety of Plozasiran in Patients With Severe Hypertriglyceridemia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Cardiology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Plozasiran (ARO-APOC3) for Severe Hypertriglyceridemia: The SHASTA-2 Randomized Clinical Trial
JAMA Cardiol 2024 Jul 01;9(7)620-630, D Gaudet, D Pall, GF Watts, SJ Nicholls, RS Rosenson, K Modesto, J San Martin, J Hellawell, CM BallantyneFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.